Clinical efficacy of 308nm single-frequency excimer laser irradiation combined with tacrolimus in the treatment of plaque-type psoriasis

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2500098158

Enrollment

Unknown

Registered

2025-03-04

Start date

2025-03-10

Completion date

Unknown

Last updated

2025-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Plaque psoriasis

Interventions

Observation Group (Tacrolimus Ointment):None

Observation Group (308nm single-frequency excimer laser irradiation combined with tacrolimus ointment):None

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Patient meets classification criteria for plaque psoriasis;

Exclusion criteria

Exclusion criteria: 1.Suffering from a mental illness and unable to cooperate with treatment;

Design outcomes

Primary

Measure	Time frame
lesion area;severity of skin lesions;	—

Secondary

Measure	Time frame
Number of Th17;Number of Th22;Number of Treg;	—

Countries

China

Contacts

Public ContactJinglin Xia

Chengdu Rheumatism Hospital

cdfsyy01@163.com+86 183 8412 5776

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026